Insights

Innovative Drug Delivery Cingulate's proprietary Precision Timed Release technology offers a differentiated approach to ADHD treatment, presenting opportunities to partner with pharmaceutical companies seeking advanced drug delivery solutions for neuropsychiatric conditions.

Pipeline Growth With positive Phase 3 trial results for CTx-1301 and plans to expand into additional therapeutic areas like anxiety disorders, Cingulate is positioned for future product launches, creating potential sales channels in the pediatric and adult mental health markets.

Market Focus Cingulate's targeted focus on frequently diagnosed conditions with burdensome dosing regimens indicates a strategic alignment with healthcare providers and payers looking to improve treatment adherence and outcomes in neuropsychiatric care.

Strategic Leadership Recent appointments of key legal and board members suggest a company preparing for scaling operations and potential partnerships, making it an attractive partner for stakeholders interested in innovative pharmaceutical technology.

Financial Opportunity With revenues estimated between 10 and 25 million dollars and ongoing pipeline development, Cingulate presents opportunities for investors and business development professionals to support or collaborate on next-generation formulations and delivery platforms.

Cingulate Inc. Tech Stack

Cingulate Inc. uses 8 technology products and services including Module Federation, Apple iCloud Mail, core-js, and more. Explore Cingulate Inc.'s tech stack below.

  • Module Federation
    Development
  • Apple iCloud Mail
    Email
  • core-js
    Javascript Libraries
  • Acquia Cloud Platform
    Platform As A Service
  • HSTS
    Security
  • Adobe Tag Manager
    Tag Management
  • YouTube
    Video Players
  • GoDaddy
    Web Hosting

Media & News

Cingulate Inc.'s Email Address Formats

Cingulate Inc. uses at least 2 format(s):
Cingulate Inc. Email FormatsExamplePercentage
FLast@cingulatetherapeutics.comJDoe@cingulatetherapeutics.com
81%
First.Last@cingulatetherapeutics.comJohn.Doe@cingulatetherapeutics.com
11%
FirstLast@cingulatetherapeutics.comJohnDoe@cingulatetherapeutics.com
4%
FMiddleLast@cingulatetherapeutics.comJMichaelDoe@cingulatetherapeutics.com
4%
FLast@cingulate.comJDoe@cingulate.com
91%
FMiddleLast@cingulate.comJMichaelDoe@cingulate.com
9%

Frequently Asked Questions

Where is Cingulate Inc.'s headquarters located?

Minus sign iconPlus sign icon
Cingulate Inc.'s main headquarters is located at 1901 West 47th Place Suite 310 Kansas City, Kansas United States. The company has employees across 1 continents, including North America.

What is Cingulate Inc.'s phone number?

Minus sign iconPlus sign icon
You can contact Cingulate Inc.'s main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Cingulate Inc.'s stock symbol?

Minus sign iconPlus sign icon
Cingulate Inc. is a publicly traded company; the company's stock symbol is CING.

What is Cingulate Inc.'s official website and social media links?

Minus sign iconPlus sign icon
Cingulate Inc.'s official website is cingulate.com and has social profiles on LinkedIn.

What is Cingulate Inc.'s NAICS code?

Minus sign iconPlus sign icon
Cingulate Inc.'s NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does Cingulate Inc. have currently?

Minus sign iconPlus sign icon
As of March 2026, Cingulate Inc. has approximately 23 employees across 1 continents, including North America. Key team members include Chief Legal Officer: N. P.Chief Medical Officer: M. B.Chief Science Officer: R. S.. Explore Cingulate Inc.'s employee directory with LeadIQ.

What industry does Cingulate Inc. belong to?

Minus sign iconPlus sign icon
Cingulate Inc. operates in the Pharmaceutical Manufacturing industry.

What technology does Cingulate Inc. use?

Minus sign iconPlus sign icon
Cingulate Inc.'s tech stack includes Module FederationApple iCloud Mailcore-jsAcquia Cloud PlatformHSTSAdobe Tag ManagerYouTubeGoDaddy.

What is Cingulate Inc.'s email format?

Minus sign iconPlus sign icon
Cingulate Inc.'s email format typically follows the pattern of FLast@cingulatetherapeutics.com. Find more Cingulate Inc. email formats with LeadIQ.

When was Cingulate Inc. founded?

Minus sign iconPlus sign icon
Cingulate Inc. was founded in 2012.

Cingulate Inc.

Pharmaceutical ManufacturingKansas, United States11-50 Employees

Cingulate® is a biopharmaceutical company utilizing its innovative Precision Timed Release™ (PTR) drug delivery platform technology to build and advance a pipeline of next-generation pharmaceutical products.  
 
We aim to improve the lives of patients suffering from frequently diagnosed conditions characterized by burdensome daily dosing regimens and suboptimal treatment outcomes.  
 
With an initial focus on the treatment of Attention Deficit/Hyperactivity Disorder (ADHD), we believe there are multiple therapeutic areas where our PTR technology may be employed to develop additional product candidates, notably anxiety disorders.

Section iconCompany Overview

Headquarters
1901 West 47th Place Suite 310 Kansas City, Kansas United States
Phone number
Stock Symbol
CING
NAICS Code
3254 - Pharmaceutical and Medicine Manufacturing
Founded
2012
Employees
11-50

Section iconFunding & Financials

  • $10M$25M

    Cingulate Inc.'s revenue is estimated to be in the range of $10M$25M

Section iconFunding & Financials

  • $10M$25M

    Cingulate Inc.'s revenue is estimated to be in the range of $10M$25M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.